GRP78 Activity Moderation as a Therapeutic Treatment against Obesity

Area of Science:

• Metabolic diseases
• Molecular biology
• Drug discovery

Background:

• Glucose-regulated protein 78 (GRP78) is a molecular chaperone.
• GRP78 is overexpressed in obesity, fatty liver, hyperlipidemia, and diabetes.
• GRP78 shows potential as a biomarker and therapeutic target for metabolic diseases.

Purpose of the Study:

• To review GRP78 inhibitors targeting its ATPase domain.
• To describe small molecules and proteins that bind GRP78.
• To summarize GRP78's mechanisms in lipid metabolism for anti-obesity drug development.

Main Methods:

• Literature review of GRP78 inhibitors.
• Description of small molecule and protein binders of GRP78.
• Summary of GRP78's role in lipid metabolism.

Main Results:

• Identified GRP78 inhibitors targeting the ATPase domain.
• Described various small molecules and proteins that bind GRP78.
• Summarized putative mechanisms of GRP78 in regulating lipid metabolism.

Conclusions:

• GRP78 is a promising biomarker for metabolic disease progression.
• Targeting GRP78, particularly its ATPase domain, offers a potential therapeutic strategy for obesity.
• Further research into GRP78 mechanisms can guide the development of novel anti-obesity drugs.